249 related articles for article (PubMed ID: 28076416)
41. TREM2 regulates obesity-induced insulin resistance via adipose tissue remodeling in mice of high-fat feeding.
Liu C; Li P; Li H; Wang S; Ding L; Wang H; Ye H; Jin Y; Hou J; Fang X; Shu Q
J Transl Med; 2019 Sep; 17(1):300. PubMed ID: 31477129
[TBL] [Abstract][Full Text] [Related]
42. Intermittent restraint-induced sympathetic activation attenuates hepatic steatosis and inflammation in a high-fat diet-fed mouse model.
Lee SB; Kim HG; Lee JS; Kim WY; Lee MM; Kim YH; Lee JO; Kim HS; Son CG
Am J Physiol Gastrointest Liver Physiol; 2019 Dec; 317(6):G811-G823. PubMed ID: 31604029
[TBL] [Abstract][Full Text] [Related]
43. Lipotoxicity and steatohepatitis in an overfed mouse model for non-alcoholic fatty liver disease.
Gaemers IC; Stallen JM; Kunne C; Wallner C; van Werven J; Nederveen A; Lamers WH
Biochim Biophys Acta; 2011 Apr; 1812(4):447-58. PubMed ID: 21216282
[TBL] [Abstract][Full Text] [Related]
44. Reduction of obesity-associated white adipose tissue inflammation by rosiglitazone is associated with reduced non-alcoholic fatty liver disease in LDLr-deficient mice.
Mulder P; Morrison MC; Verschuren L; Liang W; van Bockel JH; Kooistra T; Wielinga PY; Kleemann R
Sci Rep; 2016 Aug; 6():31542. PubMed ID: 27545964
[TBL] [Abstract][Full Text] [Related]
45. Honokiol attenuates diet-induced non-alcoholic steatohepatitis by regulating macrophage polarization through activating peroxisome proliferator-activated receptor γ.
Zhong X; Liu H
J Gastroenterol Hepatol; 2018 Feb; 33(2):524-532. PubMed ID: 28670854
[TBL] [Abstract][Full Text] [Related]
46. Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development.
Mouries J; Brescia P; Silvestri A; Spadoni I; Sorribas M; Wiest R; Mileti E; Galbiati M; Invernizzi P; Adorini L; Penna G; Rescigno M
J Hepatol; 2019 Dec; 71(6):1216-1228. PubMed ID: 31419514
[TBL] [Abstract][Full Text] [Related]
47. Chronic calcitriol supplementation improves the inflammatory profiles of circulating monocytes and the associated intestinal/adipose tissue alteration in a diet-induced steatohepatitis rat model.
Su YB; Li TH; Huang CC; Tsai HC; Huang SF; Hsieh YC; Yang YY; Huang YH; Hou MC; Lin HC
PLoS One; 2018; 13(4):e0194867. PubMed ID: 29684027
[TBL] [Abstract][Full Text] [Related]
48. Diosmin ameliorates inflammation, insulin resistance, and fibrosis in an experimental model of non-alcoholic steatohepatitis in rats.
Gerges SH; Wahdan SA; Elsherbiny DA; El-Demerdash E
Toxicol Appl Pharmacol; 2020 Aug; 401():115101. PubMed ID: 32512072
[TBL] [Abstract][Full Text] [Related]
49. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
[TBL] [Abstract][Full Text] [Related]
50. Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122.
Chai C; Cox B; Yaish D; Gross D; Rosenberg N; Amblard F; Shemuelian Z; Gefen M; Korach A; Tirosh O; Lanton T; Link H; Tam J; Permyakova A; Ozhan G; Citrin J; Liao H; Tannous M; Hahn M; Axelrod J; Arretxe E; Alonso C; Martinez-Arranz I; Betés PO; Safadi R; Salhab A; Amer J; Tber Z; Mengshetti S; Giladi H; Schinazi RF; Galun E
Gastroenterology; 2020 Sep; 159(3):999-1014.e9. PubMed ID: 32450149
[TBL] [Abstract][Full Text] [Related]
51. Resveratrol reduces the inflammatory response in adipose tissue and improves adipose insulin signaling in high-fat diet-fed mice.
Ding S; Jiang J; Wang Z; Zhang G; Yin J; Wang X; Wang S; Yu Z
PeerJ; 2018; 6():e5173. PubMed ID: 29967759
[TBL] [Abstract][Full Text] [Related]
52. Altered endocannabinoid signalling after a high-fat diet in Apoe(-/-) mice: relevance to adipose tissue inflammation, hepatic steatosis and insulin resistance.
Bartelt A; Orlando P; Mele C; Ligresti A; Toedter K; Scheja L; Heeren J; Di Marzo V
Diabetologia; 2011 Nov; 54(11):2900-10. PubMed ID: 21847582
[TBL] [Abstract][Full Text] [Related]
53. CCR2 antagonism improves insulin resistance, lipid metabolism, and diabetic nephropathy in type 2 diabetic mice.
Kang YS; Lee MH; Song HK; Ko GJ; Kwon OS; Lim TK; Kim SH; Han SY; Han KH; Lee JE; Han JY; Kim HK; Cha DR
Kidney Int; 2010 Nov; 78(9):883-94. PubMed ID: 20686445
[TBL] [Abstract][Full Text] [Related]
54. Propagermanium, a CCR2 inhibitor, attenuates cerebral ischemia/reperfusion injury through inhibiting inflammatory response induced by microglia.
He S; Liu R; Li B; Huang L; Fan W; Tembachako CR; Zheng X; Xiong X; Miyata M; Xu B; Li Y; Fang W
Neurochem Int; 2019 May; 125():99-110. PubMed ID: 30794846
[TBL] [Abstract][Full Text] [Related]
55. Attenuation by Tetrahydrocurcumin of Adiposity and Hepatic Steatosis in Mice with High-Fat-Diet-Induced Obesity.
Pan MH; Chen JW; Kong ZL; Wu JC; Ho CT; Lai CS
J Agric Food Chem; 2018 Dec; 66(48):12685-12695. PubMed ID: 30415544
[TBL] [Abstract][Full Text] [Related]
56. An increase in the circulating concentration of monocyte chemoattractant protein-1 elicits systemic insulin resistance irrespective of adipose tissue inflammation in mice.
Tateya S; Tamori Y; Kawaguchi T; Kanda H; Kasuga M
Endocrinology; 2010 Mar; 151(3):971-9. PubMed ID: 20056828
[TBL] [Abstract][Full Text] [Related]
57. Telmisartan attenuates progression of steatohepatitis in mice: role of hepatic macrophage infiltration and effects on adipose tissue.
Kudo H; Yata Y; Takahara T; Kawai K; Nakayama Y; Kanayama M; Oya T; Morita S; Sasahara M; Mann DA; Sugiyama T
Liver Int; 2009 Aug; 29(7):988-96. PubMed ID: 19386026
[TBL] [Abstract][Full Text] [Related]
58. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
[TBL] [Abstract][Full Text] [Related]
59. Phlorizin Supplementation Attenuates Obesity, Inflammation, and Hyperglycemia in Diet-Induced Obese Mice Fed a High-Fat Diet.
Shin SK; Cho SJ; Jung UJ; Ryu R; Choi MS
Nutrients; 2016 Feb; 8(2):92. PubMed ID: 26891322
[TBL] [Abstract][Full Text] [Related]
60. Intervention with a caspase-1 inhibitor reduces obesity-associated hyperinsulinemia, non-alcoholic steatohepatitis and hepatic fibrosis in LDLR-/-.Leiden mice.
Morrison MC; Mulder P; Salic K; Verheij J; Liang W; van Duyvenvoorde W; Menke A; Kooistra T; Kleemann R; Wielinga PY
Int J Obes (Lond); 2016 Sep; 40(9):1416-23. PubMed ID: 27121255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
